Explore the Efficacy and Safety of FMT With Different Bacterial Doses in the Treatment of Hepatic Encephalopathy

NAActive, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions
Hepatic Encephalopathy
Interventions
OTHER

Fecal Microbiota Transplantation

Fecal microbiota transplantation (FMT) refers to the transplantation of functional flora from healthy people's feces into patients' intestines to rebuild new intestinal flora and achieve the treatment of intestinal and parenteral diseases. In this study, 100 patients with recurrent hepatic encephalopathy were randomly divided into 1:1 groups to receive FMT with different amounts of bacteria, observe the therapeutic effect and adverse reactions of hepatic encephalopathy, and evaluate the effectiveness and safety of the two groups of patients. At the same time, the blood and stool samples of patients with recurrent hepatic encephalopathy before and after FMT were collected clinically, the composition of bile acid and other metabolites in stool and serum samples was analyzed, and the effective core flora was identified to clarify the mechanism of intestinal bacteria transplantation for the treatment of recurrent hepatic encephalopathy.

Trial Locations (1)

310000

Shulan (Hangzhou) Hospital, Hangzhou

All Listed Sponsors
lead

Hainv Gao

OTHER